Cannabidiol has been found to act as an antagonist of GPR55, a G protein-coupled receptor and putative cannabinoid receptor that is expressed in the caudate nucleus and putamen in the brain.[31] It has also been found to act as an inverse agonist of GPR3, GPR6, and GPR12.[12] Although currently classified as orphan receptors, these receptors are most closely related phylogenetically to the cannabinoid receptors.[12] In addition to orphan receptors, CBD has been shown to act as a serotonin 5-HT1A receptor partial agonist,[32] and this action may be involved in its antidepressant,[33][34] anxiolytic,[34][35] and neuroprotective effects.[36][37] It is an allosteric modulator of the μ- and δ-opioid receptors as well.[38] The pharmacological effects of CBD have additionally been attributed to PPARγ agonism and intracellular calcium release.[7]
Mike, what kind of breast cancer (invasive ductal, I presume)? How many of her lymph nodes were positive? How big was the primary tumor? Reason I ask is that in women with Stage I or IIA tumors that are estrogen-and progesterone-receptor-positive and HER2-negative (ER+/PR+/HER2-) with three or fewer positive lymph nodes, there is a genomic assay test on a sample of the tumor, called OncotypeDX, that will tell doctors whether chemo is necessary or would even work at all. Medicare covers that test 100%.That type of breast cancer mentioned above, which I had as Stage IA, is treated in postmenopausal women with anti-estrogen drugs called aromatase inhibitors(aka AIs: anastrazole, letrozole, or exemestane)which have as a side effect joint pain. CBD oil is effective for this joint pain it is not, I repeat, NOT a substitute for chemo, radiation or these anti-estrogen drugs.So don’t assume your mom’s cancer will require chemo; but if it does, CBD helps with those side effects as well. If she lives in a state where medical marijuana is legal, there are doctors who sub-specialize in certifying applications for a medical marijuana card, and in the interim before the card is issued can advise as to the appropriate dose of CBD oil (legal and over-the-counter in all 50 states). Some (though not most) medical oncologists will certify their own patients’ medical marijuana card applications so she need not seek out another doctor; and will advise the appropriate dose for her symptoms. Once she gets her card, the “budtenders” in the licensed dispensaries can advise her as to the right CBD product (with or without THC), strength, and dosage. If she lives in a state where recreational weed is legal, the “budtenders” in the marijuana shops can steer her to the right strength of CBD oil and the right dosage.
Rosenberg, Tsien, Whalley, and Devinsky (2015) have recently reviewed the role of cannabinoids in epilepsy; highlighting proconvulsive effects (e.g., THC) and anticonvulsive effects (e.g., cannabidiol). The mechanisms of action of cannabidiol in epilepsy have also been recently reviewed (Reddy & Golub, 2016). Much work with SCB in epilepsy has focused on WIN55,212-2. WIN55,212-22 potentiated the effects of four antiepileptic drugs (carbamazepine, phenytoin, phenobarbital, and valproate) in mice (Luszczki et al., 2011). However, the authors also caution that impairment of motor coordination, long-term memory, and a reduction of skeletal muscular strength was also seen with these combination treatments. The same group found WIN 55,212-2 in combination with lamotrigine, pregabalin, and topiramate and second- and third-generation anticonvulsants gabapentin, levetiracetam but not lacosamide, oxcarbazepine, pregabalin, and tiagabine to potentiate anticonvulsant effects in mice (Florek-Luszczki et al., 2015; Luszczki, Wlaz, Karwan, Florek-Luszczki, & Czuczwar, 2013).
To date, 23 states and the District of Columbia have passed laws allowing marijuana to be used for a variety of medical conditions. Fifteen additional states have enacted laws intended to allow access to CBD oil and/or high-CBD strains of marijuana. Interest in the potential therapeutic effects of CBD has been growing rapidly, partially in response to media attention surrounding the use of CBD oil in young children with intractable seizure disorders including Dravet syndrome and Lennox-Gastaut syndrome. While there are promising preliminary data, the scientific literature is currently insufficient to either prove or disprove the efficacy and safety of CBD in patients with epilepsy.i and further clinical evaluation is warranted. In addition to epilepsy, the therapeutic potential of CBD is currently being explored for a number of indications including anxiety disorders, substance use disorders, schizophrenia, cancer, pain, inflammatory diseases and others. My testimony will provide an overview of what the science tells us about the therapeutic potential of CBD and of the ongoing research supported by NIH in this area.

The CBs hold much promise in not only improving stroke but also traumatic and anoxic brain injury outcome. There is a rise in evidence that the endocannabinoids and botanical nonpsychoactive cannabidiol derivatives from the cannabis plant have a multitude of beneficial effects, particularly with ischemic stroke. Animal models of stroke have shown cannabidiol increases cerebral blood flow (CBF) mediated by 5-hydroxytryptamine (serotonin) receptor 1A (5HT1A) receptors and induces vasorelaxation [12].
In 2019, the European Food Safety Authority (EFSA) announced that CBD and other cannabinoids would be classified as "novel foods",[84] meaning that CBD products would require authorization under the EU Novel Food Regulation stating: because "this product was not used as a food or food ingredient before 15 May 1997, before it may be placed on the market in the EU as a food or food ingredient, a safety assessment under the Novel Food Regulation is required."[85] The recommendation – applying to CBD extracts, synthesized CBD, and all CBD products, including CBD oil – was scheduled for a final ruling by the European Commission in March 2019.[84] If approved, manufacturers of CBD products would be required to conduct safety tests and prove safe consumption, indicating that CBD products would not be eligible for legal commerce until at least 2021.[84]
Generally speaking, unsaturated fats, monounsaturated fats and polyunsaturated fats are regarded as healthier than saturated fats, since they lower cholesterol, and therefore, reduce your risk of heart disease and stroke. But while the consumption of saturated fat has traditionally been linked to heart disease, it’s worth noting that science continues to go back and forth in regard to whether or not saturated fats are actually healthy. As for medium chain triglycerides, these are linked to increased endurance, weight loss and lowered cholesterol, so they’re totally good for you.

When it comes to your health, "fat" is not necessarily a dirty word. You need some fat in your diet, and it actually performs some pretty impressive tasks like boosting energy, supporting cell growth, protecting your organs, keeping your body warm, and aiding in nutrient absorption and the manufacturing of hormones, according to the American Heart Association (AHA). And oils can be a great source of these healthy fats, but choosing the right variety is key.

Multiple sclerosis (MS). There is inconsistent evidence on the effectiveness of cannabidiol for symptoms of multiple sclerosis. Some early research suggests that using a cannabidiol spray under the tongue might improve pain and muscle tightness in people with MS. However, it does not appear to improve muscle spasms, tiredness, bladder control, the ability to move around, or well-being and quality of life.

Dosage For Cbd Oil


CBD interacts with the body through the endogenous cannabinoid system (ECS) or endocannabinoid system. First discovered in the late 1980’s, the endocannabinoid system regulates the body’s homeostasis, or general state of balance, impacting such functions as mood, sleep, appetite, hormone regulation, and pain and immune response. Like an acrobat on a highwire, as the environment around us impacts our normal balance, the endocannabinoid system “corrects” by mediating our body’s reaction to keep us level.

I did an analysis of 10 diffirent CBD oils and Medterras 3000mg bottle is the most cost effective per mg. Their product also appears the safest with where they source their materials and how they conduct their business. There were no issues with the ordering process and I received my product in a timely fashion as well. There is almost no taste to the oil and I take 25 ml (25 mg) twice daily with excellent results. I finely feel calm and sleep well. I am also able to focus better and get more done each day, which was an unexpected bonus. I was very sceptical about CBD at first. I have tried everything for my anxiety, and although some of the traditional drugs work, their side effects negate any benefits. I was feeling very frustrated and hopeless and ordered the CBD out of desperation. Im glad I took the chance. Well, it wasnt really a chance; I read every research article I could get my hands on and was swayed by the emerging data. I guess it was more of a leap of faith in a product that had such high claims and no healthcare gatekeepers. I have had no side effects though. The only negative is the cost.
There are thousands of unique varieties of hemp. The cultivars used for CBD oil contain significantly higher concentrations of CBD than others. Using these uniquely potent plants, it is possible to extract cannabis oil that contains significant levels of cannabidiol, as well as essential vitamins, minerals, fatty acids, terpenes, flavonoids, and other non-psychoactive cannabinoids.
It’s also one of the strongest and most concentrated CBD products on the market today. With a grain-of-rice-sized recommended serving taken orally twice a day, its potent punch acts quickly—in just ten to fifteen minutes—to provide powerful relief. Furthermore, it offers terrific value for your money, boasting more CBD per dollar than many other CBD products.
×